Literature DB >> 23452101

A case of CD20-positive peripheral T-cell lymphoma treated with rituximab and multiagent chemotherapy.

Masahiro Kamata1, Makoto Sugaya, Tomomitsu Miyagaki, Koya Sonoda, Yohei Ichimura, Hiroshi Mitsui, Shinichi Sato, Yasuhiko Kamikubo, Mineo Kurokawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23452101     DOI： 10.1111/j.1365-4632.2012.05483.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  3 in total

1.  Multispectral Imaging Approach to the Diagnosis of a CD20+ Cutaneous T-cell Lymphoproliferative Disorder: A Case Report.

Authors:  Katrin A Salva; Daniel Bennett; Jack Longley; Joan Guitart; Gary S Wood
Journal:  Am J Dermatopathol       Date:  2015-10       Impact factor: 1.533

Review 2.  CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review.

Authors:  Yasutaka Kakinoki; Junichi Hashiguchi; Takashi Ishio; Koji Chiba; Daisuke Niino; Koichi Ohshima
Journal:  Int J Hematol       Date:  2015-08-07       Impact factor: 2.490

3.  CD20+ cutaneous T-cell lymphoma with phenotypic shift after treatment with rituximab: Case report and review of the literature.

Authors:  Amanda J Tschetter; Faraaz Zafar; Margaret S Moye; Grant K Ghahramani; Brian L Swick; Brian K Link; Vincent Liu
Journal:  JAAD Case Rep       Date:  2020-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.